-Yuichiro Ohe Researcher Activity Profile

Research Author Detailed Information 

Yuichiro Ohe Publication Rate By Year

Yuichiro Ohe has published 1 paper(s) in 1976, 1 paper(s) in 1979, 1 paper(s) in 1980, 1 paper(s) in 1982, 1 paper(s) in 1983, 1 paper(s) in 1985, 1 paper(s) in 1986, 1 paper(s) in 1990, 1 paper(s) in 1994, 18 paper(s) in 2007, 4 paper(s) in 2008, for a total of 31 research publications in total.

Yuichiro Y Ohe Author Information

LAST NAME: ohe

FIRST NAME: Yuichiro

INITIALS: y

AFFILIATION:

Papers

Yuichiro Ohe's Publication Record

1. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
2. Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
3. Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues. Year Published: 1994
Department of Internal Medicine (Section 1), Sapporo Medical University School of Medicine.
4. Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan.
5. Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Year Published: 2007
Divisions of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
6. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Year Published: 2007
Department of Respiratory Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan. cri@med.juntendo.ac.jp
7. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
8. Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Year Published: 2007
Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1 Tsukuji, Chuo-ku, Tokyo, Japan.
9. Resolution of anomeric 2-amino-2-deoxy-d-glycosides by cation-exchange chromatography. Year Published: 1976
10. Human spleen histone H2B. Isolation and amino acid sequence. Year Published: 1979
11. Human spleen histone H2A. Isolation and four variant sequences. Year Published: 1980
12. Human spleen histone H3. Isolation and amino acid sequence. Year Published: 1982
13. Human spleen histone H4. Isolation and amino acid sequence. Year Published: 1983
14. Improved procedures for automated liquid phase sequence analyses of protein and peptide. Year Published: 1985
15. Human spleen histone H1. Isolation and amino acid sequence of a main variant, H1b. Year Published: 1986
16. Human spleen histone H1. Isolation and amino acid sequences of three minor variants, H1a, H1c, and H1d. Year Published: 1990
Department of Protein Chemistry, Gunma University.
17. Influence of intraoperative conversion from off-pump to on-pump coronary artery bypass grafting on costs and quality of life: a cost-effectiveness analysis. Year Published: 2007
Department of Anesthesiology, Toho University School of Medicine, Tokyo, Japan.
18. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Year Published: 2007
Department of Respiratory Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan. cri@med.juntendo.ac.jp
19. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
20. Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Year Published: 2007
Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1 Tsukuji, Chuo-ku, Tokyo, Japan.
21. Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects: SLCO1B1(*)17 is More Prevalent Than (*)15. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences.
22. Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences.
23. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
24. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
25. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
26. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
27. Influence of intraoperative conversion from off-pump to on-pump coronary artery bypass grafting on costs and quality of life: a cost-effectiveness analysis. Year Published: 2007
Second Department of Anesthesiology, Toho University School of Medicine, Meguro-ku, Tokyo, Japan. qzx02115@nifty.com <qzx02115@nifty.com>
28. Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma. Year Published: 2008
Department of Cancer and Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. toyooka@md.okayama-u.ac.jp
29. Influence of Previous Chemotherapy on the Efficacy of Subsequent Docetaxel Therapy in Advanced Non-small Cell Lung Cancer Patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
30. A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer. Year Published: 2008
Okayama Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital, Okayama, Japan. kkiura@md.okayama-u.ac.jp
31. Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.